Know Cancer

or
forgot password

Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients


Phase 4
18 Years
N/A
Not Enrolling
Both
Skin Cancer

Thank you

Trial Information

Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients


Photosensitivity of the skin to UVA and UVB in renal transplant recipients with and without
azathioprine will be determined. Azathioprine will be discontinued and photosensitivity
determined after a wash-out period of three months

- Trial with medicinal product

Inclusion Criteria


Inclusion criteria:

- Renal transplant recipients under azathioprin

Exclusion criteria:

- Treatment with Prograf (Tacrolimus)

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Photosensitivity of the skin to UVA and UVB

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

G√ľnther Hofbauer, M.D

Investigator Role:

Principal Investigator

Investigator Affiliation:

UniversitaetsSpital Zuerich

Authority:

Switzerland: Swissmedic

Study ID:

2007DR2040

NCT ID:

NCT00492895

Start Date:

June 2007

Completion Date:

March 2011

Related Keywords:

  • Skin Cancer
  • Skin Neoplasms

Name

Location